GlassScriptPhysician profile
Amal M Omran
NPI 1144355934
$300.97
in general payments reported to CMS, 2019-2025
9 companies · $22.07 in 2025
The $22.07 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $48.23 · 2023: $39.23 · 2024: $54.99 · 2025: $22.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.30 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.30 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $109.15 | 2019 | |
| Harmony Biosciences LLC | $54.99 | 2024 | |
| Abbvie INC. | $26.72 | 2019-2020 | |
| Gilead Sciences, INC. | $23.51 | 2020 | |
| Celgene Corporation | $23.27 | 2023 | Zeposia |
| Ucb, INC. | $22.07 | 2025 | Bimzelx |
| Ardelyx, INC. | $15.96 | 2023 | Ibsrela |
| Currax Pharmaceuticals LLC | $13.54 | 2020 | |
| Lupin INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amal Omran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.